Nanosonics Ltd NAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- A$2.80
- Day Range
- A$2.79–2.86
- 52-Week Range
- A$2.64–4.76
- Bid/Ask
- A$2.80 / A$2.86
- Shares Outstanding
- 299.17M
- Market Cap
- A$855.62M
- Volume/Avg
- 896,009 / 984,309
Key Statistics
- Price/Earnings (Normalized)
- 38.43
- Price/Sales
- 4.26
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.31%
Company Profile
Nanosonics Ltd is engaged in the manufacturing, service and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories; and research, development and commercialization of infection control and decontamination products and related technologies. Its products are divided into two categories: Ultrasound Reprocessing solutions, and Endoscope Reprocessing solutions. The company operates in a single segment being the healthcare equipment segment which manufactures and commercializes infection control and decontamination products and related technologies. Geographically, it operates in Australia, North America, Europe and Middle East, and Asia Pacific.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 400
- Website
- https://www.nanosonics.com.au
Valuation
|
Metric
|
NAN
|
|---|---|
Price/Earnings (Normalized) | 38.43 |
Price/Book Value | 3.86 |
Price/Sales | 4.26 |
Price/Cash Flow | 38.52 |
Price/Earnings
NAN
Financial Strength
|
Metric
|
NAN
|
|---|---|
Quick Ratio | 4.64 |
Current Ratio | 5.56 |
Interest Coverage | 9.52 |
Quick Ratio
NAN
Profitability
|
Metric
|
NAN
|
|---|---|
Return on Assets (Normalized) | 7.72% |
Return on Equity (Normalized) | 10.18% |
Return on Invested Capital (Normalized) | 8.03% |
Return on Assets
NAN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|%gQf@&! | LOCK|Yl? | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|@$# | LOCK|l%Xq | $52B | |||
| ResMed Inc
RMD
| LOCK|^N$@gx>? | LOCK|vTh? | $34B | |||
| Alcon Inc
ALC
| LOCK|SCh^SSm | LOCK|$?t!$ | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|D$mbh!X | LOCK|ft$<& | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|hl!B^tZG | LOCK|V< | $27B | |||
| Solventum Corp
SOLV
| LOCK|Q!MKX?D | LOCK|^rP | $15B | |||
| Baxter International Inc
BAX
| LOCK|cL# | LOCK|qVR# | $13B | |||
| Repligen Corp
RGEN
| LOCK|K$nLn>z | LOCK|&m>V< | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|#$@f&#k | LOCK|$@!$ | $11B |
United States